ezogabine has been researched along with vx-770 in 1 studies
Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (vx-770) | Trials (vx-770) | Recent Studies (post-2010) (vx-770) |
---|---|---|---|---|---|
383 | 26 | 241 | 753 | 60 | 731 |
Protein | Taxonomy | ezogabine (IC50) | vx-770 (IC50) |
---|---|---|---|
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.57 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hussar, DA | 1 |
1 other study(ies) available for ezogabine and vx-770
Article | Year |
---|---|
New drugs 2013, Part I.
Topics: Aminophenols; Anilides; Antibodies, Monoclonal, Humanized; Axitinib; Benzodiazepines; Carbamates; Clobazam; Diterpenes; Drug Approval; gamma-Glutamyl Hydrolase; Glucosylceramidase; Humans; Imidazoles; Indans; Indazoles; Peptides; Phenylenediamines; Prostaglandins F; Pyridines; Quinolones | 2013 |